Trial intelligence / Profile preview

Preoperative vs Postoperative TCF in Gastric Cancer

NCT00005060Phase 3Completed

Sponsor
Swiss Group for Clinical Cancer Research
Start
Nov 1999
Primary completion
Nov 2005
Modality
Small Molecules
Countries
2
01

Overview

A Phase 3 trial of docetaxel, cisplatin, fluorouracil in gastric cancer (GC), sponsored by Swiss Group for Clinical Cancer Research. Started Nov 1999; status: completed.

02

Drugs

docetaxelcisplatinfluorouracil
03

Conditions

gastric cancer (GC)

Beyond the preview

Go deeper on NCT00005060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call